Oncology

Transitions in care for patients with head and neck cancer remain a critical challenge, with new research revealing substantial evidence gaps.

Neurocognitive functioning declines across central nervous system cancers, shaped by tumor location and interacting treatment effects.

Cannabis laws were associated with lower opioid dispensing among commercially insured patients with cancer across U.S. states.

Melanoma quality of life differs during and after immunotherapy, with fatigue, skin issues, and sexual dysfunction.

The six-minute walking test offers an objective, low-cost assessment of postoperative recovery after pancreatic surgery.

High-risk women had limited awareness yet strong support for breast cancer polygenic risk scores in clinical risk assessment more.

Health-related quality of life remains significantly underreported in trials evaluating tyrosine kinase inhibitors and immune checkpoint inhibitors for early-stage non-small cell lung cancer.

A multimodal AI model has achieved significant advances in pan-cancer prognosis prediction by combining pathology images, genomics, and clinical data.